Objective. These analyses examined opioid initiation and chronic use among Iraq (OIF) and Afghanistan (OEF/OND) veterans with a new diagnosis of traumatic brain injury (TBI) in the Veterans Health Administration (VHA).
Methods. Data were obtained from national VHA data repositories. Analyses included OEF/OIF/OND veterans with a new TBI diagnosis in 2010-2012 who used the VHA at least twice, had not received a VHA opioid prescription in the 365 days before diagnosis, and had at least 365 days of data available after TBI diagnosis.
Results. Analyses included 35,621 veterans. Twenty-one percent initiated opioids; among new initiators, 23% used chronically. The mean dose was 24.0 mg morphine equivalent dose (MED) daily (SD 5 24.26); mean days supplied was 60.52 (SD 5 74.69). Initiation was significantly associated with age 36-45 years (odds ratio [OR] 5 1.09, 95% CI 5 1.01-1.17, P 5 0.04), female gender (OR 5 1.22, P < 0.001), having back pain (OR 5 1.38, P < 0.0001), arthritis/joint pain (OR 5 1.24, P < 0.0001), or neuropathic pain (OR 5 1.415, P < 0.02). In veterans age 36-45 years, those living in small rural areas had higher odds of chronic opioid use (OR 5 1.31, P < 0.0001, and OR 5 1.33, P 5 0.006, respectively) and back pain (OR 5 1.36, P 5 0.003). Headache/ migraine pain was associated with decreased odds of chronic opioid use (OR 5 0.639, P 5 0.003).
Conclusions. Prevalence of opioid use is relatively low among OEF/OIF/OND veterans with newly diagnosed TBI who are using VHA. Among those who initiated opioids, about 25% use them chronically.
Introduction
Traumatic brain injury (TBI) has been called the "signature injury" of the conflicts in Iraq and Afghanistan [1, 2] . An estimated 12-23% of veterans who served in Afghanistan (Operation Enduring Freedom [OEF] ) and Iraq (Operation Iraqi Freedom [OIF] and Operation New Dawn [OND] ) and who utilized Veterans Health Administration (VHA) care experienced a TBI while deployed [3] . Among the 613,391 returning veterans from Afghanistan and Iraq between 2009 and 2011, 40 .2% have a primary pain diagnosis, 29.4% have a primary post-traumatic stress disorder (PTSD) diagnosis, and 9.6% have a primary TBI diagnosis. Among all veterans with TBI, a significant majority (62.5%) suffered from comorbidities related to pain and PTSD [4] .
TBI is defined as a physical force to the brain sufficient to cause structural alteration or physiological disruption of brain functions that results in altered consciousness, amnesia, change in mental state, neurological deficits, or intracranial lesions [5] . TBI severity is generally categorized as mild, moderate, or severe, depending on the patient's level of arousal/consciousness at the time of injury, the duration of any loss of consciousness, and the duration of post-traumatic amnesia [6] . An estimated 50% of injuries are mild, with fewer veterans presenting to VHA care having moderate to severe TBI. Symptoms associated with TBI are typically physical symptoms, cognitive impairment, and emotional/behavioral problems [5, 7] . Symptoms can resolve in as little as a few minutes or over a few days to weeks, particularly in mild TBI. However, in some cases, symptoms continue for months to years, not just in patients with moderate to severe TBI, but also in those categorized as having a mild injury [8] .
Among civilians, patients with TBI are five times more likely to report persistent pain compared with those without TBI [4, 8, 9 ]. An epidemiologic analysis of TBI among OEF/OIF/OND veterans from 2010-2012 found that 71% of those with TBI had head, back, or neck pain, compared with only 33% of those without TBI [10] . A review of 23 studies of chronic headaches after TBI reported a prevalence of 57.8% (95% CI ¼ 55.5-50.2) when combining civilian and military cohorts [11, 12] . Although there is evidence that pain may be more prevalent immediately following TBI, pain can persist and even worsen in the years after even a mild TBI. Indeed, pain related to TBI has been documented in veterans up to five years after the initial injury [13] . While a headache is the most commonly documented pain condition, back and neck pain and neuropathic pain are also common [8] .
TBI is also associated with a range of mental health comorbidities, particularly PTSD and depression. Estimates of the prevalence of PTSD among veterans with mild TBI range from 14% to 77% [2, [14] [15] [16] [17] [18] [19] . Estimates of the prevalence of major depressive disorder comorbidity with TBI range from 3% to 53% [11, 14, [20] [21] [22] . This is particularly striking when considering that the 12-month prevalence of depression in the general adult population is approximately 6.7% [11, 23] .
The high rates of comorbid pain and mental health (MH) diagnoses are particularly concerning when considering risks of opioid use in veterans with TBI. Opioid medications have become a common treatment for noncancer pain [24] [25] [26] . Increased opioid use has been accompanied by increased opioid misuse, emergency department visits, overdoses, and automobile accidents [27] [28] [29] [30] [31] . Factors that increase the likelihood of chronic opioid use include chronic noncancer pain, having diagnoses of MH and substance use disorders (SUD; i.e., PTSD, depression, nonopioid SUD, opioid SUD, tobacco use), and demographic characteristics (male gender, younger age, Caucasian race) [32] [33] [34] [35] [36] [37] . Among OEF/OIF/OND veterans with TBI and chronic noncancer pain, those with a PTSD diagnosis have a higher relative risk of receiving opioid medications for 20 or more consecutive days in the year following the pain diagnosis (TBI þ PTSD adjusted relative risk [RR] ¼ 2.95, 95% confidence interval [CI] ¼ 2.79-3.12) than those without PTSD (TBI without PTSD adjusted RR ¼ 1.77, 95% CI ¼ 1.60-1.95, P < 0.01) [27] . However, there is little information about the factors, other than PTSD, associated with opioid initiation among veterans with TBI not previously using opioids, regardless of pain condition, nor is there information about the factors associated with chronic use after opioid initiation. The overarching goal of this work is to understand how opioids are used in patients with TBI. To that end, the current study identified a cohort of OEF/OIF/OND veterans who are regular users of VHA care and who had a recent diagnosis of TBI, but who had not used opioids in the 365 days prior to the TBI diagnosis. We hypothesized that diagnoses of chronic pain and comorbid diagnosis of PTSD, depression, or nonopioid SUD would be associated with opioid initiation and chronic opioid use among OEF/OIF/ OND veterans with TBI.
The high prevalence of comorbidities related to pain and MH makes this veteran population more likely to use opioids and therefore more susceptible to possible adverse effects. Identifying the factors related to the initiation and chronic use of opioids could educate and inform clinicians as to the characteristics that may put patients at high risk for poor outcomes and could provide them with the ability to reevaluate treatment decisions to minimize these risks. The evidence gained from this investigation can also provide data to VHA policy makers and motivate changes in policies concerning this population.
Methods

Data Sources
Data for this study were obtained using three VHA data repositories: the Veterans Administration (VA) Corporate Data Warehouse (CDW), the OEF/OIF/OND Roster, and the VA Pharmacy Benefits Management Service (PBM). The project received approval from the institutional review boards of the Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences. A data use agreement was executed with each repository.
Study Sample
We identified a study cohort of OEF/OIF/OND veterans who used VHA care at least twice in the 365 days prior to the index period but did not have an outpatient opioid prescription from a VHA provider in that time frame. This provided a cohort of patients who were known to be using VHA care and therefore had an opportunity to receive an opioid prescription from VHA but did not. As they were required to use the VHA at least twice, it implies some level of engagement in care and potentially increases the likelihood of getting prescription medications from the VHA rather than from an outside provider.
Included veterans had:
1. at least one TBI diagnosis in FY10 or later (the date of the first TBI diagnosis identified was assigned as the veteran's index date);
2. at least 365 days of observation available prior to the date of TBI diagnosis (this requirement decreases the risk that the veteran had been receiving treatment for TBI outside VHA);
3. at least two VHA outpatient visits in the 365 days after diagnosis.
Excluded veterans had:
1. an opioid prescription or visit to a methadone clinic before the identified index date;
2. residence in a VHA nursing home or domiciliary, or were enrolled in VHA hospice care in the 365 days prior to the index date;
3. an opioid prescription in injectable or suppository form or had incomplete opioid prescription records 365 days after the index date;
4. an average daily dose greater than 1,000 mg MED daily (these were treated as potentially invalid values and excluded from the analyses to protect against data entry errors);
5. a date of opioid initiation 90 or fewer days from the end of the observation period (this was to ensure the possibility of measuring chronic opioid use).
The final cohort of veterans had a new TBI diagnosis within VHA in FY10 and were regular users of VHA care but were not living in an environment that would influence how prescription medications are managed (e.g., domiciliary or nursing home) or had conditions where opioid prescribing could systematically differ from prescribing for noncancer pain (e.g., cancer diagnosis or hospice care).
Opioid Use
Data from the VHA PBM were used to create variables for opioid use. This was based on the days covered by prescriptions issued by the VHA in the 12 months after the index date. Any opioid use was defined as a VHA outpatient opioid prescription for any length of time in the 12 months after the index date. Chronic opioid use was defined as 91 or more days of outpatient opioid use issued by a VHA pharmacy in the 12 months after the index date. To calculate the number of opioid days covered, the prescriptions for the 12 months after the index date were sorted into chronological order based on the date dispensed. If any two prescriptions overlapped by more than 20% or more than 10 days, the overlapping portions of the prescription were assumed to be taken concurrently and the overlapping days were only included once in the opioid days' calculation. If the overlap was 20% or less and 10 or fewer days, the second prescription was shifted and the overlapping days from both the first and second prescription were included in the opioid days' calculation. To further describe opioid use in this cohort, the mean daily opioid dose in morphine equivalents was calculated for each opioid user, referred to as the morphine equivalent dose. The MED was calculated by multiplying the quantity of each prescription by the strength of the prescription (milligrams of opioid per unit dispensed). The quantity-strength of the product was then multiplied by conversion factors derived from published sources to estimate the milligrams of morphine equivalent to the opioids dispensed in the prescription [38] [39] [40] .
TBI Definition
The CDW was used to identify veterans with at least one outpatient visit coded with an ICD-9 code for TBI. These codes were selected based on a literature review [41, 42] and VHA publications [5] .
Other Variables
Demographic and diagnostic data included the following: date of birth, race, marital status, gender, zip code, and diagnosis codes (ICD-9). The zip code was used to classify veterans as living in an urban area, large rural city/town, small rural town, or isolated small rural town [43] . We identified common painful conditions experienced by veterans: neck, back, arthritis/joint, headache/ migraine, neuropathic, and pain due to traumatic limb injuries, fractures, and amputations. These conditions were selected based on a literature search; they were found to be common among veterans, including those with TBI [9, 44] . The definition of chronic pain requires at least two separate occasions of a pain diagnosis at least 30 but not more than 365 days apart. The ICD-9 codes used to identify veterans with these pain conditions are listed in Appendix Table A1 . Veterans were categorized as having a painful condition if they had at least one outpatient visit coded with that condition within the 12-month period after the index date, and a second code for a painful condition at least 30 days but not more than 365 days later. While these are common chronic conditions, veterans in these analyses could have had chronic and nonchronic painful conditions we did not identify. However, given that these pain conditions are common among OEF/OIF/OND veterans and among those with TBI, they serve as appropriate tracer conditions in this cohort. Dummy variables were created to identify veterans with at least one recorded diagnosis of major depressive disorder, PTSD, alcohol use disorder, nonopioid SUD, opioid use disorder, or tobacco use. Definitions for these conditions are based on previous literature [34, 45] and are consistent with definitions used by the VA Office of Mental Health Operations.
Military Characteristics
Military characteristics and education have been shown to be associated with persistent pain [9, 46] . The OEF/ OIF/OND Roster was used to identify both military characteristics including rank (enlisted, officer, warrant), component (reserve, guard, active duty), branch (Army, Navy, Air Force, Marines), and education level for subjects included in the analyses.
Analysis
Multivariable logistic regression was used to model the odds of initiating opioid use in the 12 months after the index date and to identify factors associated with chronic opioid use among opioid initiators. Veterans using VHA care are clustered within clinics that are clustered within medical centers. To avoid underestimating the standard error and erroneously identifying a variable as statistically significant, the VA Medical Center was specified as a random effect in each model.
Results
A total of 35,621 veterans met inclusion/exclusion criteria (see Table 1 ). There were no other statistically significant clinical characteristics associated with chronic opioid use. Interestingly, those with a diagnosis of chronic pain were not statistically more likely to use opioids chronically, nor were those with a diagnosis of depression, PTSD, alcohol disorders, or other substance use disorders.
Discussion
In these analyses, opioids were initiated in slightly more than 20% of the OEF/OIF/OND TBI cohort, but among opioid initiators, almost 25% used opioids chronically. This chronic use, however, is lower than in all veterans. In other analyses, we found that among all opioid users with chronic noncancer pain in the VHA nationwide, almost 57% of opioid users received them chronically [24] . This may suggest that opioid prescribing from VA providers is lower among OEF/OIF/OND veterans with TBI compared with other veteran cohorts. This finding may also be a function of the sample. We observed this cohort for 365 days after the index period. It is possible that opioid initiation may occur later than the first year after a diagnosis, suggesting that other pain management strategies may be used during that time. It is also possible that patients with new TBI diagnoses within the VA are less likely to initiate opioids within the VA compared with veterans who are treated in other health care systems before more than 120 mg MED/day [47] . Opioid initiators were more likely to have at least one pain diagnosis compared with those who did not initiate opioid medications. It is also important to note that diagnoses such as alcohol disorder and SUDs were not associated with opioid initiation. Several of our findings are notably different than other studies examining opioid use in veterans. Other authors have found that male gender was associated with opioid use, including chronic opioid use [24, 34, 36] . However, in the current analyses, women were more likely to initiate opioids but not to use them chronically. This is a particularly interesting finding given that other studies have found that painful conditions such as musculoskeletal, headache, and back pain may be more common among women veterans, particularly those who served in Iraq and Afghanistan, than among their male counterparts [48] . Female veterans are more likely than male veterans to report severe pain and pain that interferes in their daily lives, to have an emergency department or primary care visit for a pain-related problem, to have a service-connected disability rating, and to have a rating of at least 50% [9, [48] [49] [50] . In our cohort, 20% of women had a chronic pain diagnosis, compared with only 14% of men (X2 ¼ 46.82, P < 0.0001).
In these analyses, education appeared to have a protective effect. Veterans in this cohort who had a bachelor's degree or higher were less likely to initiate opioids or use them chronically. Improving education among veterans may offer a target for a policy initiative that could benefit veterans and decrease risk of opioid initiation and chronic use.
In our analyses, neither PTSD nor depression was associated with opioid initiation or chronic opioid use. Previous work found that PTSD and depression were associated with increased odds of receiving opioids and of receiving them chronically, but most of those studies were in cohorts of veterans known to have chronic, painful conditions and used data from as far back as 2005. It is important to note that these analyses depended on diagnoses of mental health conditions that were documented in the VA medical record. It is possible that veterans in this cohort had comorbid mental health conditions that were undiagnosed or not documented in the VA electronic health record. Data for the current analyses are from 2010 and later. In 2009 and 2010, the VHA implemented new policies designed to decrease chronic opioid use and increase monitoring to identify opioid misuse [51] [52] [53] . The lack of association between opioid use and depression and PTSD may be a result of these policies. We reported earlier that depression, PTSD, and substance use disorders were not associated with opioid continuation beyond 90 days of use in the veteran population, as we have found in the civilian population [54] .
The proportion of veterans with documented smoking in this study was approximately 12%. In other studies, smoking prevalence was approximately 23-30% [34, 45] . This difference is likely related to the way we identified smoking in the cohort. We used one ICD-9 CM code for smoking (305.1, tobacco use disorder) and no V codes or supplementary codes for a history of smoking. Other authors used a wide range of codes that included the history of tobacco use; we limited the code used to identify current tobacco use only. Given the difference in identification of tobacco use and that it was not associated with opioid initiation but was associated with statistically lower odds of chronic use, it will be important to further examine this issue in future research.
Approximately 15% of the cohort had a pain diagnosis, which is lower than the epidemiologic estimates of pain conditions among veterans with TBI [10] [11] [12] . This low prevalence is likely due to the definition of a painful condition. The first date of TBI diagnosis in FY10 or later was considered the index date; veterans were followed for the 365-day period following the index date. The definition of chronic pain required at least two separate occasions of a pain diagnosis at least 30 but not more than 365 days apart. However, the goal was not to determine whether opioids were prescribed only in response to a pain diagnosis or to identify all diagnoses for which opioids are prescribed. The goal was to identify factors associated with opioid initiation among veterans with TBI as a cohort who had not used opioids in the previous 365-day period and had a relatively new TBI diagnosis, thereby making it possible to understand opioid initiation. The numerous pain conditions in this study served as tracer conditions to help understand the clinical conditions of these veterans, a strategy used in other studies [25] . Therefore, the findings likely cannot be generalized to all veterans or others with TBI or pain. However, it does help to understand how opioids are used in OEF/OIF/OND veterans with TBI who have a relatively new diagnosis.
Limitations
One of the challenges of studying TBI using data repositories is that there is no way to account for the severity of TBI or how recently it occurred. While the proposed inclusion/exclusion criteria used in these analyses will not necessarily completely identify veterans with a "new" TBI diagnosis, TBI not being coded by a VA provider in the previous 12 months may suggest that treatment related to TBI was not a key clinical focus in the 365 days prior to the index date. Other studies have noted that mild TBI is the most common type of TBI presenting to the VHA for care, so it is likely that most of the cases identified in these analyses are also mild TBI. It is also possible that some veterans who experienced TBI may not be diagnosed. Therefore, it is likely that the current findings are most generalizable to veterans who are newly diagnosed with TBI in the VHA.
Another key limitation of this study is the lack of information about opioid use and receipt of medical care outside the VHA. Identifying opioid prescriptions obtained from non-VHA providers is very difficult. To decrease the risk of underestimating opioid use because of non-VHA prescribing, we identified veterans who used VHA care at least twice in the 365 days prior to the index period but who did not have an outpatient opioid prescription from a VHA provider in that time frame. This implies some level of engagement in care and potentially increases the likelihood of veterans mainly getting their prescription medications from the VHA rather than from an outside provider. Therefore, the findings from these analyses are likely generalizable to veterans within VHA who are using VHA care regularly. These veterans are also the ones most likely to be affected by systemwide policies and interventions related to opioid use.
Conclusion
These data suggest that the prevalence of opioid use is relatively low among OEF/OIF/OND veterans with newly diagnosed TBI who are using the VHA, but among those who initiated opioids, about 25% use them chronically. Prescribing was mostly limited to moderate doses, with most veterans using opioids for approximately two months of the 12-month study period. Future analyses should seek to better understand factors that influence outcomes of TBI and opioid use in this cohort, including longer observation periods to examine the trajectory of opioid use and gender-related differences in chronic use among opioid initiators.
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